Inhibitors of janus kinases
View Patent ↗The instant invention provides for tetracyclic compounds that inhibit the four known mammalian JAK kinases (JAK1, JAK2, JAK3 and TYK2) and PDK1. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting the activity of JAK1, JAK2, JAK3 TYK2 and PDK1 by administering the compound to a patient in need of treatment for myeloproliferative disorders or cancer.
1. A compound of the formula
wherein R 1 is aryl, wherein said aryl, groups is optionally substituted with one to three substituents independently selected from the group consisting of halo, hydroxyl, C 1-6 alkyl, O(C 1-6 alkyl), R 3 and halolakyl;
R 2 is heteroaryl, wherein said heteroaryl, group is optionally substituted with one to three substituents independently selected from the group consisting of R 3 , hydroxyl, cyano, halo, C 1-6 alkyl, O(C 1-6 alkyl), O(C 1-6 alkyl)R 3 , (C 1-6 alkyl)R 3 , (C═O)R 3 , OR 3 , (C═O)R 3 OH, (C═O)R 3 O(C 1-6 alkyl), (C═O)O(C 1-6 alkyl), R 3 (C═O)O(C 1-6 alkyl), SO m R 3 , SO m R 4 , (C═O)NR 4 R 5 , (C═O)NR 4 (C 1-6 alkyl)R 3 ; (C═O)NR 4 (C 1-6 alkyl)NR 4 R 5 , (C═O)O(C 1-6 alkyl), (C═O)NR 4 SO m (C 1-6 alkyl), NR 4 R 5 , (C═O)NR 4 R 5 , N(R 3 ) 2 , NR 4 (C 1-6 alkyl)R 3 , NR 4 (C═O)C 1-6 alkyl, NR 4 SO m (C 1-6 alkyl), (C 1-6 alkyl)NR 4 R 5 and NHSO m N(R 3 ) 2 ;
each R 3 is independently aryl, heteroaryl, heterocyclyl or C 3-8 cycloalkyl, wherein said aryl, heteroaryl, heterocyclyl and cycloalkyl groups are optionally substituted with one to three halo, hydroxyl or C 1-6 alkyl;
R 4 is hydrogen or C 1-6 alkyl;
R 5 is hydrogen or C 1-6 alkyl;
m is an integer from zero to two;
or a pharmaceutically acceptable salt or stereoisomer thereof.
2. The compound of claim 1 wherein R 1 is phenyl substituted with two halo; or a pharmaceutically acceptable salt or stereoisomer thereof.
3. The compound of claim 1 wherein R 2 is heteroaryl, wherein said heteroaryl group is optionally substituted with one to three substituents independently selected from the group consisting of R 3 , hydroxyl, cyano or halo; or a pharmaceutically acceptable salt or stereoisomer thereof.
4. The compound of claim 3 wherein R 2 is heteroaryl, wherein said heteroaryl group is optionally substituted with one to three substituents independently selected from the group consisting of hydroxyl, cyano and halo; or a pharmaceutically acceptable salt or stereoisomer thereof.
5. The compound of claim 3 wherein R 2 is heteroaryl wherein said heteroaryl group is optionally substituted with one to two substituents independently selected from the group consisting of hydroxyl, cyano and halo; or a pharmaceutically acceptable salt or stereoisomer thereof.
6. The compound which is:
2-cyclopentyl-9-(1-methyl-1H-pyrazol-4-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluoropheny)-9-(6-chloropyridin-3-yl)-3,6-dihydro-7H-benzo [h]imidazo[4,5-f]isoquinolin-7-one;
9-(5-chloropyridin-2-yl)-2-(2,6-difluorophenyl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-(2,6-difluoropyridin-3-yl)-3,6-dihydro-7H-benzo [h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chlorophenyl)-9-(1-methyl-1H-pyrazol-4-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chlorophenyl)-9-pyridin-4-yl-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chlorophenyl)-9-pyridin-3-yl-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chlorophenyl)-9-[2(4-methylpiperazin-1-yl)pyridine-4-yl]-3,6-dihydro-7H-benzo [h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chlorophenyl)-9-(1H-pyrazol-3-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chlorophenyl)-9-[4-methylpiperazin-1-yl)pyridin-3-yl]-3,6-dihydro-7H-benzo [h]imidazo[4,5-f]isoquinolin-7-one;
2-cyclopentyl-9-(1H-pyrazol-3-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
9-(1H-pyrazol-3-yl)-2-(tetrahydrofuran-3-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
9-(1H-pyrazol-3-yl)-2-(tetrahydrofuran-3 -yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-cyclopentyl-9-(6-methoxypyridin-3-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-cyclopentyl-9-(1H-pyrazol-4-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-cyclopentyl-9-(2,6-dimethoxypyridin-3-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-cyclopentyl-9-pyrimidin-5-yl-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-cyclopentyl-9-(3,5-dimethylisoxazol-4-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-(1H-pyrazol-3-yl)-1,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-(1H-pyrazol-4-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-pyridin-3-yl-1,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-(2-morpholin-4-ylpyridin-4-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-pyridin-4-yl-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
9-(6-aminopyridin-3-yl)-2-(2-chloro-6-fluorophenyl)-3,6-dihydro-7H-benzo [h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-(6-methoxypyridin-3-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-(4-methoxypyridin-3-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-{6-[(2-morpholin-4-ylethyl)amino]pyridin-3-yl}-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-(6-hydroxypyridin-3-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-(5-chloro-2-methoxypyridin-4-yl)-3,6-dihydro-7H-benzo [h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-(6-chloropyridin-3-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-[2-(cyclopropylmethoxy)pyridin-3-yl]-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one; p 1 2-(2-chloro-6-fluorophenyl)-9-(6-fluoropyridin-3-yl)-3,6-dihydro-7H-benzo [h]imidazo[4,5-f]isoquinolin-7-one;
5-[2-(2-chloro-6-fluorophenyl)-7-oxo-6,7-dihydro-3H-benzo[h]imidazo[4,5-f ]isoquinolin-9-yl]pyridine-2-carbonitrile;
2-(2-chloro-6-fluorophenyl)-9-(2,6-difluoropyridin-3-yl)-3,6-dihydro-7H-benzo [h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-(6-methylpyridin-3-yl)-3,6-dihydro-7H-benzo [h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-pyrimidin-5-yl-3,6-dihydro-7H-benzo[h]imidazo[4,5-f ]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-quinolin-3-yl-3,6-dihydro-7H-benzo[h]imidazo[4,5-f ]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-[6-(dimethylamino)pyridin-3-y]-3,6-dihydro-7H-benzo [h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-(3-furyl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f ]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-(1-methyl-1H-pyrazol-4-yl)-3,6-dihydro-7H-benzo [h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-(2,6-dimethoxypyridin-3yl)-3,6-dihydro-7H-benzo [h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-(3,5-dimethyl-1H-pyrazol-4-yl)-3,6-dihydro-7H-benzo [h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-(1,3,5-trimethyl-1H-pyrazol-4-yl)-3,6-dihydro-7H-benzo [h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-isoquinolin-4-yl-3,6-dihydro-7H-benzo[h]imidazo[4,5-f ]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-(2-methoxypyrimidin-5-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-(6-morpholin-4-ylpyridin-3-yl)-3,6-dihydro-7H-benzo [h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-(2-methoxypyridin-3-yl)-3,6-dihydro-7H-benzo [h]imidazo[4,5-f]isoquinolin-7-one;
2-(2-chloro-6-fluorophenyl)-9-(2-fluoroquinolin-3-yl)-3,6-dihydro-7H-benzo [h]imidazo[4,5-f]isoquinolin-7-one;
2-(2,6-difluorophenyl)-9-(1-methyl-1H-pyrazol-4-yl)-3,6-dihydro-7H-benzo [h]imidazo[4,5-f]isoquinolin-7-one;
2-(2,6-difluorophenyl)-9-(6-fluoropyridin-3-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-(2,6-difluorophenyl)-9-(2-fluoropyridin-4-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-(2,6-difluorophenyl)-9-(5-fluoropyridin-3-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-(2,6-difluorophenyl)-9-(5-fluoropyridin-2-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f ]isoquinolin-7-one;
2-(2,6-difluorophenyl)-9-(3-fluoropyridin-4-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f ]isoquinolin-7-one;
9-(2-chloropyridin-4-yl)-2-(2,6-difluorophenyl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f ]isoquinolin-7-one;
2-(2,6-difluorophenyl)-9-(6-fluoropyridin-2-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f ]isoquinolin-7-one;
9-(5-chloropyridin-2-yl)-2-(2,6-difluorophenyl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f]isoquinolin-7-one;
2-(2,6-difluorophenyl)-9-(6-methoxypyridin-2-yl)-3,6-dihydro-7H-benzo[h]imidazo[4,5-f ]isoquinolin-7-one;
2-(2,6-difluorophenyl)-9-pyridin-2-yl-3,6-dihydro-7H-benzo[h]imidazo[4,5-f ]isoquinolin-7-one;
or a pharmaceutically acceptable salt or stereoisomer thereof.
7. A pharmaceutical composition comprising a pharmaceutically effective amount of the compound according to claims 1 , and a pharmaceutically acceptable carrier.